<html>
<head>PUBMED IDs for EPM2B</head>
<body bgcolor='#C5F0F2'><h1>EPM2B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12958597/'>Mutations in NHLRC1 cause progressive myoclonus epilepsy.</a> September 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12960212/'>Genetic mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22.</a> September 10  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15304597/'>Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus.</a> August 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15781812/'>Lafora disease due to EPM2B mutations: a clinical and genetic study.</a> March 23  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16134145/'>Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EPM2B) genes.</a> September 1  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16190947/'>Late-onset and slow-progressing Lafora disease in four siblings with EPM2B mutation.</a> September 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16190942/'>Hyperhomocysteinemia in children treated with antiepileptic drugs is normalized by folic acid supplementation.</a> September 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16190936/'>Association analysis of malic enzyme 2 gene polymorphisms with idiopathic generalized epilepsy.</a> September 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17304172/'>[Lafora's disease (EPM2)].</a> February 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18029386/'>Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.</a> November 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18263761/'>Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate.</a> February 12  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19744044/'>22-year-old girl with status epilepticus and progressive neurological symptoms.</a> November 5  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19951852/'>Lafora disease and congenital generalized lipodystrophy: a case report.</a> February 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20538597/'>Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.</a> August 31  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20858601/'>Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin.</a> May 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20873469/'>[Myoclonic epilepsy of Lafora: a case report].</a> December 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21505799/'>Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21728993/'>Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21738631/'>A PTG variant contributes to a milder phenotype in Lafora disease.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22047982/'>Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.</a> June 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22369717/'>Lafora progressive myoclonus epilepsy: recent insights into cell degeneration.</a> October 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22369697/'>A role for Cdkl1 in the development of gastric cancer.</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22669944/'>Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.</a> October 19  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22961547/'>Early-onset Lafora body disease.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23904258/'>Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.</a> April 12  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24838580/'>Increased oxidative stress and impaired antioxidant response in Lafora disease.</a> March 10  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25015673/'>Three patients with lafora disease: different clinical presentations and a novel mutation.</a> January 20  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25015671/'>Epidemiology of Giardia duodenalis infection in ruminant livestock and children in the Ismailia province of Egypt: insights by genetic characterization.</a> April 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25246353/'>Late onset Lafora disease and novel EPM2A mutations: breaking paradigms.</a> June 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25416783/'>Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25680286/'>Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.</a> July 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26278982/'>Polyglucosan storage myopathies.</a> September 9  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27702709/'>Lafora disease.</a> October 6  2016<br></body></html>
